Cite
SAT-372-High prevalence of anti HLA Class II de novo donor-specific antibodies during rejection after liver transplantation.
MLA
Colmenero, Jordi, et al. “SAT-372-High Prevalence of Anti HLA Class II de Novo Donor-Specific Antibodies during Rejection after Liver Transplantation.” Journal of Hepatology, vol. 70, Apr. 2019, p. e798. EBSCOhost, https://doi.org/10.1016/S0618-8278(19)31592-0.
APA
Colmenero, J., Ruiz, P., Flores, N., Vasquez, M., Raquel, G., Crespo, G., Martorell, J., & Navasa, M. (2019). SAT-372-High prevalence of anti HLA Class II de novo donor-specific antibodies during rejection after liver transplantation. Journal of Hepatology, 70, e798. https://doi.org/10.1016/S0618-8278(19)31592-0
Chicago
Colmenero, Jordi, Pablo Ruiz, Nayelli Flores, Monica Vasquez, Garcia Raquel, Gonzalo Crespo, Jaume Martorell, and Miquel Navasa. 2019. “SAT-372-High Prevalence of Anti HLA Class II de Novo Donor-Specific Antibodies during Rejection after Liver Transplantation.” Journal of Hepatology 70 (April): e798. doi:10.1016/S0618-8278(19)31592-0.